Prevalence of Ascending Aortic Dilation in Sports Medicine
PRAADS
1 other identifier
observational
400
1 country
1
Brief Summary
This study aims to assess the prevalence of ascending aortic dilation in athletes from the general population undergoing routine sports medicine evaluation. It also evaluates the predictive factors and the reproducibility of focused cardiac ultrasound.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2025
CompletedFirst Submitted
Initial submission to the registry
March 21, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedFirst Posted
Study publicly available on registry
July 3, 2025
CompletedJuly 3, 2025
March 1, 2025
1 year
March 21, 2025
July 2, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Prevalence of Ascending Aortic Dilation in Athletes
Proportion of athletes (recreational and competitive) identified with ascending aortic dilation, as determined by focused cardiac ultrasound. Dilation is defined as an aortic diameter ≥ 40 mm and/or a Z-score ≥ 2, according to age-adjusted reference values.
Baseline
Secondary Outcomes (1)
Predictive Factors for Ascending Aortic Dilation
Baseline
Study Arms (1)
Recreational and competitive Athletes
All athletes aged over 10 years consulting for routine sports medicine evaluation, regardless of sport type or performance level.
Interventions
A focused cardiac ultrasound will be performed to measure the dimensions of ascending aorta
Eligibility Criteria
The study population includes recreational and competitive athletes aged 10 years and older who consulted the Sports Medicine Department at Caen University Hospital for a routine pre-participation cardiovascular evaluation, and who underwent focused cardiac ultrasound of the ascending aorta as part of a standardized screening protocol.
You may qualify if:
- Individuals aged 10 years and older
- Consulting for a pre-participation sports medicine evaluation at the Caen University Hospital
- No known history of cardiovascular disease
- Underwent a focused cardiac ultrasound (FCU) of the ascending aorta as part of the consultation
- Consent given for use of anonymized medical data for research purposes
You may not qualify if:
- Previous diagnosis of aortic disease or cardiovascular malformation
- Incomplete or non-interpretable FCU images
- Existing cardiology follow-up with echocardiography less than 3 years old
- Refusal to participate or opposition to data use
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Caen Normandie
Caen, 14000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 21, 2025
First Posted
July 3, 2025
Study Start
January 1, 2024
Primary Completion
January 1, 2025
Study Completion
June 1, 2025
Last Updated
July 3, 2025
Record last verified: 2025-03